Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
Revenue projections:
Revenue projections for ANURAS ANURAS's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.
Financial Ratios:
currentRatio
1.454000
forwardPE
54.335056
debtToEquity
37.505000
earningsGrowth
1.603000
revenueGrowth
1.488000
grossMargins
0.465650
operatingMargins
0.141810
trailingEps
13.650000
forwardEps
22.468000
Anupam Rasayan India Ltd's current ratio being 1.454 suggests that the company has no issue servicing its short-term debt. Its strong liquidity position, supported by sufficient cash reserves and current assets, ensures that Anupam Rasayan India Ltd can meet its financial obligations with ease. Anupam Rasayan India Ltd's forward PE ratio is too high, which may hinder future price growth and increase the risk of a price correction. Investors should carefully evaluate this metric along with other key financial indicators to get a full picture of the stock's potential. Anupam Rasayan India Ltd's positive earnings and revenue growth signal the company's business is on track for further expansion. These strong financial trends suggest that Anupam Rasayan India Ltd will continue to grow its operations, driven by increasing profits and revenue. ANURAS's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that ANURAS is likely to outperform its previous year's financial performance.
Price projections:
Price projections for ANURAS The stock price of ANURAS has often been near the lower end of projections, indicating that it may not be meeting investor expectations. This trend could suggest challenges ahead for the company.
Recommendation changes over time:
Recommendations trend for ANURAS
Analysts' buy bias toward ANURAS suggests the stock is seen as a solid investment, potentially motivating investors to consider it for their portfolios. With this positive outlook, ANURAS is likely to be viewed as a secure place to allocate funds, driving further interest in the stock.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An investor-focused analysis of how 2025 tariffs are reaching consumers in 2026,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.